Nursing

Gene

Biology

Computer security

Mutation

Computer science

Genetics

Exome sequencing

Pediatrics

Genetic testing

Diagnostic test

Medical genetics

Exome

Family medicine

Internal medicine

Authorization

Medicine

Prior authorization

Genetics in Medicine

<h2>Abstract</h2><h3>Purpose</h3> Genetic testing is an important diagnostic tool in pediatric genetics clinics, yet many patients face barriers to testing. We describe the outcomes of prior authorization requests (PARs) for genetic tests, one indicator of patient access to clinically recommended testing, in pediatric genetics clinics. <h3>Methods</h3> We retrospectively reviewed PARs for genetic tests (<i>n</i> = 4,535) recommended for patients <18 years of age (<i>n</i> = 2,798) by pediatric medical geneticists at two children's hospitals in Texas, 2017–2018. We described PAR outcomes, accompanying diagnostic codes, and diagnostic yield. <h3>Results</h3> The majority (79.9%) of PARs received a favorable outcome. PARs submitted to public payers were more likely to receive a favorable outcome compared with private payers (85.5% vs. 70.3%, respectively; <i>p</i> < 0.001). No diagnostic codes were associated with higher likelihood of PAR approval for exome sequencing. Among the 2,685 tests approved and completed, 522 (19.4%) resulted in a diagnosis. <h3>Conclusion</h3> Though there was a high PAR approval rate, our findings suggest that insurance coverage remains one barrier to genetic testing. When completed, genetic testing had a high yield in our sample. Further evidence of clinical utility and development of clinical practice guidelines may inform payer medical policy development and improve access to testing in the future.

Outcomes of prior authorization requests for genetic testing in outpatient pediatric genetics clinics